Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22127805)

1.

Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status.

Hao D, Lau HY, Eliasziw M, Box A, Diaz R, Klimowicz AC, Shin B, Lees-Miller SP, Magliocco AM.

Head Neck. 2012 Jun;34(6):785-91. doi: 10.1002/hed.21817. Epub 2011 Aug 24.

PMID:
22127805
2.

Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.

Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova AS, Golemis EA, Flieder DB, Cooper HS, Lango M, Ridge JA, Burtness B.

Clin Cancer Res. 2013 Dec 1;19(23):6633-43. doi: 10.1158/1078-0432.CCR-13-0152. Epub 2013 Oct 2.

3.

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation.

Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, Ahn YC, Jeong HS, Son YI, Baek JH, Park K.

Br J Cancer. 2008 Jul 8;99(1):167-72. doi: 10.1038/sj.bjc.6604464.

4.

ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation.

De Castro G Jr, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH.

Oncol Rep. 2011 Mar;25(3):693-9. doi: 10.3892/or.2011.1133. Epub 2011 Jan 3.

PMID:
21206986
5.

ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.

Patel MR, Zhao N, Ang MK, Stadler ME, Fritchie K, Weissler MC, Zanation AM, Harris SL, Funkhouser WK, Olshan AF, Shores CG, Hayes DN.

Otolaryngol Head Neck Surg. 2013 Oct;149(4):587-95. doi: 10.1177/0194599813496522. Epub 2013 Jul 11.

PMID:
23846458
7.

DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors.

Lima LM, de Souza LR, da Silva TF, Pereira CS, Guimarães AL, de Paula AM, de Andrade Carvalho H.

Histopathology. 2012 Feb;60(3):489-96. doi: 10.1111/j.1365-2559.2011.04062.x. Epub 2011 Dec 16.

PMID:
22176134
8.

Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy.

Bišof V, Jakovčević A, Seiwerth S, Rakušić Z, Gašparov S.

J Cancer Res Clin Oncol. 2013 Feb;139(2):187-94. doi: 10.1007/s00432-012-1318-8. Epub 2012 Sep 26.

PMID:
23011763
9.

Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck.

Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q.

Cancer. 2002 Jan 15;94(2):393-7.

PMID:
11900225
10.
11.
12.

Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer.

Yang M, Kim WH, Choi Y, Lee SH, Kim KR, Lee HS, Tae K.

Eur J Cancer Prev. 2006 Jun;15(3):269-73.

PMID:
16679872
13.

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML.

J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12.

14.

Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.

Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y.

Clin Cancer Res. 1999 Apr;5(4):801-6.

15.

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer.

Dudás J, Schartinger VH, Romani A, Schweigl G, Kordsmeyer K, Marta PI, Url C, Kral F, Riechelmann H.

Tumour Biol. 2014 Aug;35(8):7807-19. doi: 10.1007/s13277-014-2001-2. Epub 2014 May 12.

16.

DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.

Sturgis EM, Dahlstrom KR, Spitz MR, Wei Q.

Arch Otolaryngol Head Neck Surg. 2002 Sep;128(9):1084-8.

PMID:
12220217
17.

HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.

Rautava J, Kuuskoski J, Syrjänen K, Grenman R, Syrjänen S.

J Clin Virol. 2012 Feb;53(2):116-20. doi: 10.1016/j.jcv.2011.11.005. Epub 2011 Dec 15.

PMID:
22177275
18.

Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.

Tseden-Ish M, Choi YD, Cho HJ, Ban HJ, Oh IJ, Kim KS, Song SY, Na KJ, Ahn SJ, Choi S, Kim YC.

Respirology. 2012 Jan;17(1):127-33. doi: 10.1111/j.1440-1843.2011.02060.x.

PMID:
21899657
19.

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D.

J Clin Oncol. 2007 Nov 20;25(33):5172-9.

20.

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.

J Clin Oncol. 2006 Sep 10;24(26):4333-9. Epub 2006 Aug 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk